UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040041
Receipt number R000045649
Scientific Title Function of steamed soy foods
Date of disclosure of the study information 2020/04/25
Last modified on 2020/04/03 11:24:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of continuous intake of steamed soy foods on muscle mass and strength of healthy people with insufficient exercise

Acronym

Soy foods

Scientific Title

Function of steamed soy foods

Scientific Title:Acronym

Soy

Region

Japan


Condition

Condition

Healthy people with insufficient exercise

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Although soy protein has been shown to exhibit anti-muscle atrophy, the utility of whole soybeans is not yet well understood. Tofu and soy milk rich in soy protein, but other active ingredients may have escaped. Therefore, the anti-muscular atrophy effect of steamed soybeans as whole soybeans that are easy to eat and easy to digest and absorb is examined in humans with insufficient exercise.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Measurement of muscle mass and intramuscular fat mass by MRI examination,
Grip strength, walking speed measurement, vertical jump measurement

Key secondary outcomes

Body weight


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Eating steamed soy food for 30 days

Interventions/Control_2

Non-eating steamed soy food

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

healthy humans with insufficient exercise

Key exclusion criteria

1) Patients who are currently in treatment or have a disease.
2) People who are currently treating with diet or exercise therapy under the supervision of a doctor
3) People who have a pacemaker or metal inside
4) People who are pregnant, may become pregnant, or are breastfeeding
5) People who have soy food allergy
6) Patients with a history of severe liver, kidney, or heart disease
7) People who have arrhythmia and severe anemia
8) People who take medicines, health foods, or supplements that may affect the test results
9) Others who are not qualified by the Principal Investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Nikawa

Organization

Tokushima University Graduate School

Division name

Institute of Medical Biosciences

Zip code

770-8503

Address

3-18-15 Kuramoto-cho, Tokushima 770-8503

TEL

088-633-9248

Email

nikawa@tokushima-u.ac.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Nikawa

Organization

Tokushima University Graduate School

Division name

Institute of Medical Biosciences

Zip code

770-8503

Address

3-18-15 Kuramoto-cho, Tokushima 770-8503

TEL

088-633-9248

Homepage URL


Email

nikawa@tokushima-u.ac.jp


Sponsor or person

Institute

FUJICCO

Institute

Department

Personal name



Funding Source

Organization

FUJICCO

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Integrate, Co., LTD.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Review Board, Tokushima University Hospital

Address

2-50-1 Kuramoto-cho, Tokushima 770-8503

Tel

0886-15-8512

Email

awachiken@tokushima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

徳島大学病院


Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 04 Month 25 Day

Date of IRB


Anticipated trial start date

2020 Year 04 Month 25 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 04 Month 03 Day

Last modified on

2020 Year 04 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045649


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name